BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

CDMO's Shifting Focus to Meet Future Demand

Transformational forces are influencing the global contract development and manufacturing organization (CDMO) market's growth. Disruptive, innovative busin...

April 08, 2022 | News

GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row

This marks the third consecutive year of GenScript bagging the same award in Asia Pacific region. The award also follows GenScript's re...

March 31, 2022 | News

Rentschler Biopharma and Vetter Unveil Xpert Alliance

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that t...

March 29, 2022 | News

Samsung Biologics holds 11th Annual General Meeting of Shareholders

Five matters were presented and approved unanimously at this year's meeting, which included the approval of financial statement, appointment of directors, ...

March 29, 2022 | News

New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer

The X-Cancer's investigator-led trial of SAR-bisPSMA in known or suspected prostate cancer (X-Calibur) is a Phase I/II IIT in up to 150 patients at the Uro...

March 25, 2022 | News

I Peace triples GMP cell manufacturing by expanding CDMO facility

The facility's expansion, designed to conform to GMP standard, is now almost complete and is expected to start manufacturing cGMP grade cells in April this...

March 15, 2022 | News

Singleron Acquires Proteona

Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their...

March 08, 2022 | News

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...

March 08, 2022 | News

HCmed, Formosa Lab, and Formosa Pharma Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs

By integrating HCmed's vibrating mesh nebulizers, Formosa Laboratories' drug development and manufacturing capabilities, and Formosa Pharmaceuticals' APNT ...

March 07, 2022 | News

WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

The PAI focused on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners. During a 5-day remote inspection from Novembe...

March 04, 2022 | News

Paras Biopharmaceuticals to expand global outreach of its ‘Biosimilar Development & Partnership’

Bioseet, based in Munich, Germany, is an enterprise encompassing a virtual marketplace and teamspace for Biosimilar and other generic assets to facilitate ...

March 03, 2022 | News

PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial

The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...

February 28, 2022 | News

Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYS...

February 25, 2022 | News

Catalent Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China

The facility will be expanded by approximately 30,000 square feet (approximately 2,800 square meters), which will double the clinical storage capacity...

February 16, 2022 | News

Stay Connected